COVID-19 Impact on Global Pre-Eclampsia Treatment Market Size, Status and Forecast 2020-2026

September 2020 | 94 pages | ID: C283BCF2DE5AEN
QYResearch

Abstracts

This report focuses on the global Pre-Eclampsia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pre-Eclampsia Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• A1M Pharma AB
• Alnylam Pharmaceuticals, Inc.
• Glenveigh Medical, LLC
• LFB S.A.
• Pluristem Therapeutics Inc.
• VG Life Sciences, Inc.

Market segment by Type, the product can be split into

• PLX-PAD
• RMC-035
• ALN-AGT
• Others

Market segment by Application, split into

• Clinic
• Hospital
• Research Center

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Pre-Eclampsia Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Pre-Eclampsia Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Pre-Eclampsia Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pre-Eclampsia Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Pre-Eclampsia Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 PLX-PAD
  1.4.3 RMC-035
  1.4.4 ALN-AGT
  1.4.5 Others
1.5 Market by Application
  1.5.1 Global Pre-Eclampsia Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Clinic
  1.5.3 Hospital
  1.5.4 Research Center
1.6 Coronavirus Disease 2019 (Covid-19): Pre-Eclampsia Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Pre-Eclampsia Treatment Industry
    1.6.1.1 Pre-Eclampsia Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Pre-Eclampsia Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Pre-Eclampsia Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Pre-Eclampsia Treatment Market Perspective (2015-2026)
2.2 Pre-Eclampsia Treatment Growth Trends by Regions
  2.2.1 Pre-Eclampsia Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Pre-Eclampsia Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Pre-Eclampsia Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Pre-Eclampsia Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Pre-Eclampsia Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Pre-Eclampsia Treatment Players by Market Size
  3.1.1 Global Top Pre-Eclampsia Treatment Players by Revenue (2015-2020)
  3.1.2 Global Pre-Eclampsia Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Pre-Eclampsia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pre-Eclampsia Treatment Market Concentration Ratio
  3.2.1 Global Pre-Eclampsia Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Pre-Eclampsia Treatment Revenue in 2019
3.3 Pre-Eclampsia Treatment Key Players Head office and Area Served
3.4 Key Players Pre-Eclampsia Treatment Product Solution and Service
3.5 Date of Enter into Pre-Eclampsia Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Pre-Eclampsia Treatment Historic Market Size by Type (2015-2020)
4.2 Global Pre-Eclampsia Treatment Forecasted Market Size by Type (2021-2026)

5 PRE-ECLAMPSIA TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Pre-Eclampsia Treatment Market Size by Application (2015-2020)
5.2 Global Pre-Eclampsia Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Pre-Eclampsia Treatment Market Size (2015-2020)
6.2 Pre-Eclampsia Treatment Key Players in North America (2019-2020)
6.3 North America Pre-Eclampsia Treatment Market Size by Type (2015-2020)
6.4 North America Pre-Eclampsia Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Pre-Eclampsia Treatment Market Size (2015-2020)
7.2 Pre-Eclampsia Treatment Key Players in Europe (2019-2020)
7.3 Europe Pre-Eclampsia Treatment Market Size by Type (2015-2020)
7.4 Europe Pre-Eclampsia Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Pre-Eclampsia Treatment Market Size (2015-2020)
8.2 Pre-Eclampsia Treatment Key Players in China (2019-2020)
8.3 China Pre-Eclampsia Treatment Market Size by Type (2015-2020)
8.4 China Pre-Eclampsia Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Pre-Eclampsia Treatment Market Size (2015-2020)
9.2 Pre-Eclampsia Treatment Key Players in Japan (2019-2020)
9.3 Japan Pre-Eclampsia Treatment Market Size by Type (2015-2020)
9.4 Japan Pre-Eclampsia Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Pre-Eclampsia Treatment Market Size (2015-2020)
10.2 Pre-Eclampsia Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pre-Eclampsia Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Pre-Eclampsia Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Pre-Eclampsia Treatment Market Size (2015-2020)
11.2 Pre-Eclampsia Treatment Key Players in India (2019-2020)
11.3 India Pre-Eclampsia Treatment Market Size by Type (2015-2020)
11.4 India Pre-Eclampsia Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Pre-Eclampsia Treatment Market Size (2015-2020)
12.2 Pre-Eclampsia Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Pre-Eclampsia Treatment Market Size by Type (2015-2020)
12.4 Central & South America Pre-Eclampsia Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 A1M Pharma AB
  13.1.1 A1M Pharma AB Company Details
  13.1.2 A1M Pharma AB Business Overview and Its Total Revenue
  13.1.3 A1M Pharma AB Pre-Eclampsia Treatment Introduction
  13.1.4 A1M Pharma AB Revenue in Pre-Eclampsia Treatment Business (2015-2020))
  13.1.5 A1M Pharma AB Recent Development
13.2 Alnylam Pharmaceuticals, Inc.
  13.2.1 Alnylam Pharmaceuticals, Inc. Company Details
  13.2.2 Alnylam Pharmaceuticals, Inc. Business Overview and Its Total Revenue
  13.2.3 Alnylam Pharmaceuticals, Inc. Pre-Eclampsia Treatment Introduction
  13.2.4 Alnylam Pharmaceuticals, Inc. Revenue in Pre-Eclampsia Treatment Business (2015-2020)
  13.2.5 Alnylam Pharmaceuticals, Inc. Recent Development
13.3 Glenveigh Medical, LLC
  13.3.1 Glenveigh Medical, LLC Company Details
  13.3.2 Glenveigh Medical, LLC Business Overview and Its Total Revenue
  13.3.3 Glenveigh Medical, LLC Pre-Eclampsia Treatment Introduction
  13.3.4 Glenveigh Medical, LLC Revenue in Pre-Eclampsia Treatment Business (2015-2020)
  13.3.5 Glenveigh Medical, LLC Recent Development
13.4 LFB S.A.
  13.4.1 LFB S.A. Company Details
  13.4.2 LFB S.A. Business Overview and Its Total Revenue
  13.4.3 LFB S.A. Pre-Eclampsia Treatment Introduction
  13.4.4 LFB S.A. Revenue in Pre-Eclampsia Treatment Business (2015-2020)
  13.4.5 LFB S.A. Recent Development
13.5 Pluristem Therapeutics Inc.
  13.5.1 Pluristem Therapeutics Inc. Company Details
  13.5.2 Pluristem Therapeutics Inc. Business Overview and Its Total Revenue
  13.5.3 Pluristem Therapeutics Inc. Pre-Eclampsia Treatment Introduction
  13.5.4 Pluristem Therapeutics Inc. Revenue in Pre-Eclampsia Treatment Business (2015-2020)
  13.5.5 Pluristem Therapeutics Inc. Recent Development
13.6 VG Life Sciences, Inc.
  13.6.1 VG Life Sciences, Inc. Company Details
  13.6.2 VG Life Sciences, Inc. Business Overview and Its Total Revenue
  13.6.3 VG Life Sciences, Inc. Pre-Eclampsia Treatment Introduction
  13.6.4 VG Life Sciences, Inc. Revenue in Pre-Eclampsia Treatment Business (2015-2020)
  13.6.5 VG Life Sciences, Inc. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Pre-Eclampsia Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Pre-Eclampsia Treatment Revenue
Table 3. Ranking of Global Top Pre-Eclampsia Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pre-Eclampsia Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of PLX-PAD
Table 6. Key Players of RMC-035
Table 7. Key Players of ALN-AGT
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four Pre-Eclampsia Treatment Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Pre-Eclampsia Treatment Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Pre-Eclampsia Treatment Players to Combat Covid-19 Impact
Table 14. Global Pre-Eclampsia Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Pre-Eclampsia Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Pre-Eclampsia Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Pre-Eclampsia Treatment Market Share by Regions (2015-2020)
Table 18. Global Pre-Eclampsia Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Pre-Eclampsia Treatment Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Pre-Eclampsia Treatment Market Growth Strategy
Table 24. Main Points Interviewed from Key Pre-Eclampsia Treatment Players
Table 25. Global Pre-Eclampsia Treatment Revenue by Players (2015-2020) (Million US$)
Table 26. Global Pre-Eclampsia Treatment Market Share by Players (2015-2020)
Table 27. Global Top Pre-Eclampsia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pre-Eclampsia Treatment as of 2019)
Table 28. Global Pre-Eclampsia Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Pre-Eclampsia Treatment Product Solution and Service
Table 31. Date of Enter into Pre-Eclampsia Treatment Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Pre-Eclampsia Treatment Market Size by Type (2015-2020) (Million US$)
Table 34. Global Pre-Eclampsia Treatment Market Size Share by Type (2015-2020)
Table 35. Global Pre-Eclampsia Treatment Revenue Market Share by Type (2021-2026)
Table 36. Global Pre-Eclampsia Treatment Market Size Share by Application (2015-2020)
Table 37. Global Pre-Eclampsia Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. Global Pre-Eclampsia Treatment Market Size Share by Application (2021-2026)
Table 39. North America Key Players Pre-Eclampsia Treatment Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Pre-Eclampsia Treatment Market Share (2019-2020)
Table 41. North America Pre-Eclampsia Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. North America Pre-Eclampsia Treatment Market Share by Type (2015-2020)
Table 43. North America Pre-Eclampsia Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. North America Pre-Eclampsia Treatment Market Share by Application (2015-2020)
Table 45. Europe Key Players Pre-Eclampsia Treatment Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Pre-Eclampsia Treatment Market Share (2019-2020)
Table 47. Europe Pre-Eclampsia Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Pre-Eclampsia Treatment Market Share by Type (2015-2020)
Table 49. Europe Pre-Eclampsia Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Pre-Eclampsia Treatment Market Share by Application (2015-2020)
Table 51. China Key Players Pre-Eclampsia Treatment Revenue (2019-2020) (Million US$)
Table 52. China Key Players Pre-Eclampsia Treatment Market Share (2019-2020)
Table 53. China Pre-Eclampsia Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. China Pre-Eclampsia Treatment Market Share by Type (2015-2020)
Table 55. China Pre-Eclampsia Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. China Pre-Eclampsia Treatment Market Share by Application (2015-2020)
Table 57. Japan Key Players Pre-Eclampsia Treatment Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Pre-Eclampsia Treatment Market Share (2019-2020)
Table 59. Japan Pre-Eclampsia Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Pre-Eclampsia Treatment Market Share by Type (2015-2020)
Table 61. Japan Pre-Eclampsia Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Pre-Eclampsia Treatment Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Pre-Eclampsia Treatment Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Pre-Eclampsia Treatment Market Share (2019-2020)
Table 65. Southeast Asia Pre-Eclampsia Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Pre-Eclampsia Treatment Market Share by Type (2015-2020)
Table 67. Southeast Asia Pre-Eclampsia Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Pre-Eclampsia Treatment Market Share by Application (2015-2020)
Table 69. India Key Players Pre-Eclampsia Treatment Revenue (2019-2020) (Million US$)
Table 70. India Key Players Pre-Eclampsia Treatment Market Share (2019-2020)
Table 71. India Pre-Eclampsia Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. India Pre-Eclampsia Treatment Market Share by Type (2015-2020)
Table 73. India Pre-Eclampsia Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. India Pre-Eclampsia Treatment Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Pre-Eclampsia Treatment Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Pre-Eclampsia Treatment Market Share (2019-2020)
Table 77. Central & South America Pre-Eclampsia Treatment Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Pre-Eclampsia Treatment Market Share by Type (2015-2020)
Table 79. Central & South America Pre-Eclampsia Treatment Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Pre-Eclampsia Treatment Market Share by Application (2015-2020)
Table 81. A1M Pharma AB Company Details
Table 82. A1M Pharma AB Business Overview
Table 83. A1M Pharma AB Product
Table 84. A1M Pharma AB Revenue in Pre-Eclampsia Treatment Business (2015-2020) (Million US$)
Table 85. A1M Pharma AB Recent Development
Table 86. Alnylam Pharmaceuticals, Inc. Company Details
Table 87. Alnylam Pharmaceuticals, Inc. Business Overview
Table 88. Alnylam Pharmaceuticals, Inc. Product
Table 89. Alnylam Pharmaceuticals, Inc. Revenue in Pre-Eclampsia Treatment Business (2015-2020) (Million US$)
Table 90. Alnylam Pharmaceuticals, Inc. Recent Development
Table 91. Glenveigh Medical, LLC Company Details
Table 92. Glenveigh Medical, LLC Business Overview
Table 93. Glenveigh Medical, LLC Product
Table 94. Glenveigh Medical, LLC Revenue in Pre-Eclampsia Treatment Business (2015-2020) (Million US$)
Table 95. Glenveigh Medical, LLC Recent Development
Table 96. LFB S.A. Company Details
Table 97. LFB S.A. Business Overview
Table 98. LFB S.A. Product
Table 99. LFB S.A. Revenue in Pre-Eclampsia Treatment Business (2015-2020) (Million US$)
Table 100. LFB S.A. Recent Development
Table 101. Pluristem Therapeutics Inc. Company Details
Table 102. Pluristem Therapeutics Inc. Business Overview
Table 103. Pluristem Therapeutics Inc. Product
Table 104. Pluristem Therapeutics Inc. Revenue in Pre-Eclampsia Treatment Business (2015-2020) (Million US$)
Table 105. Pluristem Therapeutics Inc. Recent Development
Table 106. VG Life Sciences, Inc. Company Details
Table 107. VG Life Sciences, Inc. Business Overview
Table 108. VG Life Sciences, Inc. Product
Table 109. VG Life Sciences, Inc. Revenue in Pre-Eclampsia Treatment Business (2015-2020) (Million US$)
Table 110. VG Life Sciences, Inc. Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Pre-Eclampsia Treatment Market Share by Type: 2020 VS 2026
Figure 2. PLX-PAD Features
Figure 3. RMC-035 Features
Figure 4. ALN-AGT Features
Figure 5. Others Features
Figure 6. Global Pre-Eclampsia Treatment Market Share by Application: 2020 VS 2026
Figure 7. Clinic Case Studies
Figure 8. Hospital Case Studies
Figure 9. Research Center Case Studies
Figure 10. Pre-Eclampsia Treatment Report Years Considered
Figure 11. Global Pre-Eclampsia Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Pre-Eclampsia Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Pre-Eclampsia Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Pre-Eclampsia Treatment Market Share by Players in 2019
Figure 16. Global Top Pre-Eclampsia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pre-Eclampsia Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Pre-Eclampsia Treatment Revenue in 2019
Figure 18. North America Pre-Eclampsia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Pre-Eclampsia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Pre-Eclampsia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Pre-Eclampsia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Pre-Eclampsia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Pre-Eclampsia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Pre-Eclampsia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. A1M Pharma AB Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. A1M Pharma AB Revenue Growth Rate in Pre-Eclampsia Treatment Business (2015-2020)
Figure 27. Alnylam Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Alnylam Pharmaceuticals, Inc. Revenue Growth Rate in Pre-Eclampsia Treatment Business (2015-2020)
Figure 29. Glenveigh Medical, LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Glenveigh Medical, LLC Revenue Growth Rate in Pre-Eclampsia Treatment Business (2015-2020)
Figure 31. LFB S.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. LFB S.A. Revenue Growth Rate in Pre-Eclampsia Treatment Business (2015-2020)
Figure 33. Pluristem Therapeutics Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Pluristem Therapeutics Inc. Revenue Growth Rate in Pre-Eclampsia Treatment Business (2015-2020)
Figure 35. VG Life Sciences, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. VG Life Sciences, Inc. Revenue Growth Rate in Pre-Eclampsia Treatment Business (2015-2020)
Figure 37. Bottom-up and Top-down Approaches for This Report
Figure 38. Data Triangulation
Figure 39. Key Executives Interviewed